Who invested in Sienna Biopharmaceuticals?
Sienna Biopharmaceuticals's investors include Fidelity, ARCH Venture Partners, Omega Funds, Altitude Life Science Ventures and Dr. David Pyott, and 1 more on record.
United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$40Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $47M sold, first sale Oct 2015
From the SEC filings it signed: 6 on the team.
On the board, as filediBob R. MoreDennis R. FentonKeith R. LeonardKristina R. BurowRobert R. Nelsen
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Sienna Biopharmaceuticals's investors include Fidelity, ARCH Venture Partners, Omega Funds, Altitude Life Science Ventures and Dr. David Pyott, and 1 more on record.
Sienna Biopharmaceuticals has raised $40M across 2 rounds since 2017. One round did not disclose an amount, so the total is a floor.
Sienna Biopharmaceuticals's most recent round was a Venture in Aug 2018.
Sienna Biopharmaceuticals's largest round on record is $40M (Series B), in Apr 2017.
Sienna Biopharmaceuticals's first round on record, in Apr 2017, was backed by Fidelity, ARCH Venture Partners and Altitude Life Science Ventures and 2 others.
Sienna Biopharmaceuticals's latest named round is a Venture, in Aug 2018.
Sienna Biopharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.